GBI International
NEW

Japan’s Regenerative Medicine: A Decade In, What’s Holding It Back?
新聞集錦
NEW

首款BRAF V600E突變大腸癌一線療法 輝瑞獲FDA批准；Vertex囊性纖維化三聯療法獲FDA批准

生技醫藥
NEW

晟德林榮錦：10億投資順藥非護盤！ 前進JPM談授權

GBI International
GBIHighlights

Taiwan's Cell Therapy: 20 Years of Progress - Reviewing Current Clinical Trials

2023-12-01/GlobalBio & Investment
Taiwan'sCellTherapy:20YearsofProgress-ReviewingCurrentClinicalTrials Themuch-debatedRegenerativeMedicineActhasbeenthesubjectofongoingdiscussionsformanyyears.Thoughithasconsolidatedfromthreedraftgu...
GBI International
GBIHighlights

The Winners of 2023 Best Bio CEO Award held by Globalbio have been revealed!

2023-12-01/GlobalBio & Investment
TheWinnersof2023BestBioCEOAwardheldbyGlobalbiohavebeenrevealed!Thisyearwehave CytoArm｜Armed-Tcelltherapy, LeadgeneBiomedical,Inc.,and SunWayBiotechCo.,LTD. winningtheawards.Thefirstwinner,CytoArm,feat...
GBI International
GBIHighlights

AI Revolutionizing Biomedicine: Recent Advances and Healthcare Applications

2023-12-01/GlobalBio & Investment
AIRevolutionizingBiomedicine:RecentAdvancesandHealthcareApplicationsAIanditsgenerativecapabilitieshavegainedsignificantattention,particularlyinthefieldofbiomedicine,sinceChatGPT'srisetoprominencei...
GBI International
GBIHighlights

Rebuilding Psychological Safety After Drug Allergy: A 4-Step Approach

2023-12-01/GlobalBio & Investment
RebuildingPsychologicalSafetyAfterDrugAllergy:A4-StepApproachAdrugallergyoccurswhentheimmunesystemreactstoanonprescription,prescription,orherbalmedicine.Patientssufferingfromdrugallergiesexperiencevar...
GBI International
GBIHighlights

LuminX Fluorescent Nano-Diamond Platform Achieves in Tracking Lung Injury, Head and Neck Cancer

2023-12-01/GlobalBio & Investment
【Editor'sChoice|PreviewofSelectedCompaniesatBIOAsia-Taiwan】LuminXFluorescentNano-DiamondPlatformAchievesinTrackingLungInjury,HeadandNeckCancer.TheinnovativetrackingplatformofLuminXcombinesnanoscal...
GBI International
GBIHighlights

EirGenix's Development Capacity Extends to CDMO and Biosimilars Across the US, Europe, and Taiwan

2023-12-01/GlobalBio & Investment
【Editor'sChoice|PreviewofSelectedCompaniesatBIOAsia-Taiwan】EirGenix'sDevelopmentCapacityExtendstoCDMOandBiosimilarsAcrosstheUS,Europe,andTaiwan. EirGenix(6589.TWO)isoneofthefewcompaniesinAsiat...
GBI International
GBIHighlights

Merck and Pythia Biotech Signed a MOU on Using Organ-on-Chip Technology to Develop...

2023-12-01/GlobalBio & Investment
MerckandPythiaBiotechSignedaMOUonUsingOrgan-on-ChipTechnologytoDevelopNext-GenerationPlatformforDrugTesting OnJune9, MerckKGaA,Darmstadt,Germany andTaiwanstartupPythiaBiotechsignedaMemorandumofUnderst...
GBI International
GBIHighlights

iXensor's CDMO New Business Model Accelerates Next-Generation At-Home Testing and...

2023-12-01/GlobalBio & Investment
【Editor'sChoice|Taiwan'sMedicalDevice】iXensor'sCDMONewBusinessModelAcceleratesNext-GenerationAt-HomeTestingandPOCTProductDevelopment iXensor(6734.TWO),establishedin2012,istheworld'sfir...
GBI International
GBIHighlights

Hospitals in Taiwan use digital technology to implement medical care

2023-12-01/GlobalBio & Investment
【Editor'sChoice|Taiwan’sMedicalDevice】Shortenunhealthylifeyears!HospitalsinTaiwanusedigitaltechnologytoimplementmedicalcare TheaveragelifeexpectancyofTaiwanesepeoplehasexceeded80years,butthe...
GBI International
GBIHighlights

Medical Taiwan Kicks Off on June 8!

2023-12-01/GlobalBio & Investment
【Editor'sChoice|Taiwan'sMedicalDevice】MedicalTaiwanKicksOffonJune8!230ExhibitorsandInternationalBuyersfrom60CountriesCreatingInfiniteBusinessesOpportunities MedicalTaiwan,hostedbytheTaiwanExte...
GBI International
GBIHighlights

Next Step: Targeting Neurological Disorders and Cancer Treatment?!

2023-12-01/GlobalBio & Investment
【Editor'sChoice|Storiesbehind #BIO2023】ModernaCo-founderandAlnylamSeniorVicePresident:WitnessingthePotentialofNucleicAcidTherapyinthePandemic!NextStep:TargetingNeurologicalDisordersandCancerTreatm...
GBI International
GBIHighlights

76-year-old CSD Successfully Transitions to B2C with Innovative 'Health in Style' Products.

2023-12-01/GlobalBio & Investment
【Editor'sChoice|Taiwan'sMedicalDevice】76-year-old #CSD SuccessfullyTransitionstoB2CwithInnovative'HealthinStyle'Products. CSD,aleadingbrandinTaiwanforhealthprotectionsupplieswitha76-ye...

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務